Quick Takeaways
- Matrix Capital Management Company, LP filed SCHEDULE 13D/A for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA).
- Disclosed ownership: 11%.
- Date of event: 16 May 2025.
Matrix Capital Management Company, LP - 16 May 2025 SCHEDULE 13D/A Report for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA)
- Filing Manager
- Matrix Capital Management Company, LP
- Reporting Manager
- Matrix Capital Management Company LP
- Symbol
- AURA
- Shares outstanding
- 61,977,350 shares
- Disclosed Ownership
- 6,922,870 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 May 2025, 16:35:51 UTC
- Date of event
- 16 May 2025
- Next filing
- 11 May 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Matrix Capital Management Company, LP disclosed 11% ownership in Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA) on 16 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 May 2025, 16:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company LP | 11% | 6,922,870 | 0 | 6,922,870 | /s/ David E. Goel | David E. Goel, Managing General Partner | 0001410830 |
| David E. Goel | 11% | 6,922,870 | 0 | 6,922,870 | /s/ David E. Goel | David E. Goel, Individually | 0001548144 |